Clinical Trial Update: Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of WC3011 (Estradiol Vaginal Cream) for vulvovaginal atrophy in postmenopausal women with dyspareunia has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• WC3011 (estradiol vaginal cream)

Snippet

Sponsor: Warner Chilcott | Conditions: Vulvovaginal Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2022-05-09